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Previewsligation of CD2 or CD28 costimulatory re-
ceptors and is associated with cofilin
dephosphorylation and activation (Sam-
stag et al., 1992). Therefore, one would
expect synergistic effects of CD100 and
JAML engagment on DETC rounding.
Irrespective of these issues, the fact
the plexin B2 is broadly expressed by
several other epithelial tissues where
resident CD100-expressing gd T cells
are located suggest a more general role
for CD100-plexin B2 interactions in the
immune control of epithelial barrier integ-
rity. Moreover, because a CD100 ortholog
is expressed by human T cells and can
modulate their effector functions (Elha-
bazi et al., 1997), semaphorin-plexin inter-196 Immunity 37, August 24, 2012 ª2012 Elsactions could similarly impact on T cell-
epithelial cell crosstalks that have been
recently evidenced in this species (Toulon
et al., 2009).REFERENCES
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Our molecular understanding of how immune cells protect epithelial cells against damage is limited. In this
issue of Immunity, Hanash et al. (2012) report that interleukin-22 produced by innate lymphoid cells provides
protection to the stem cell niche of the intestinal epithelium.Infections and infection-induced immu-
nity are often associated with collateral
damage to tissues, thereby necessitating
tissue repair. At epithelial surfaces, tissue
damage may occur frequently during
steady state due to the continuous
presence of bacteria and noxious com-
pounds. Therefore, it has been proposed
that immune cells contribute to the
protection of epithelial surfaces by
releasing factors that fortify the epithelial
barrier and promote tissue repair. How-
ever, the cell types and molecular
networks involved are poorly understood.
It is widely believed that innate or innate-
like lymphocytes at mucosal barriers
may be central regulators of such pro-
cesses. Lymphocytes located within the
epithelium (intraepithelial lymphocytes
[IELs]), in particular, the intestinal epithe-lium and the skin, were the first to be
characterized as having a regulatory
role (Jameson and Havran, 2007). For
instance, IEL residing in the epidermis of
the skin (i.e., dendritic epidermal gd
T cells) release growth factors (i.e., kerati-
nocyte growth factor, insulin-like growth
factor-1) involved in wound healing and
tissue repair.
Recently, additional subsets of innate
lymphocytes have been discovered that
are now widely referred to as innate
lymphoid cells (ILCs) (Spits and Di Santo,
2011). Numerous ILCs can be found at
mucosal surfaces, and they have added
an important facet to our understanding
of how hematopoietic cells influence
homeostasis and repair of epithelial and
mesenchymal cell types (Sanos et al.,
2011). For example, depletion of type 2ILC (ILC2) in the context of influenza infec-
tion leads to a loss of airway epithelial
integrity and impaired tissue remodeling
(Monticelli et al., 2011). The tissue-protec-
tive effect of ILC2 is at least in part medi-
ated by their production of amphiregulin,
a member of the epidermal growth factor
family that promotes repair of epithelial
cells. Another group of ILCs is develop-
mentally dependent on the transcrip-
tion factor RORgt, which they also con-
tinuously express (Spits and Di Santo,
2011). They are now generally referred to
as RORgt+ ILCs. Subsets of RORgt+
ILCs have lymphoid-tissue-inducing func-
tions, and RORgt+ ILCs are strictly
required for the formation of prenatally
developing lymph nodes and Peyer’s
patches. They are also indispensible in
the organogenesis of multiple postnatally
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tinal lymphoid follicles (Eberl et al., 2004).
Each cryptopatch constitutes an accumu-
lation of several hundred RORgt+ ILCs,
and several thousand cryptopatches are
found in the lamina propria of the small
intestine directly underlying the intestinal
crypts.
RORgt+ ILCs embody an important
source of various cytokines, in particular,
the cytokine interleukin-22 (IL-22) (Spits
and Di Santo, 2011). IL-22 is unusual in
that it acts mainly on epithelial cells
and mesenchymal stroma cells, which
express the IL-22 receptor. Thus, IL-22
signaling may constitute an important
method by which immune cells control
the function of epithelial cells. It was previ-
ously shown that mice genetically lacking
IL-22 are more susceptible to dextrane
sodium sulfate (DSS)-induced colitis (Su-
gimoto et al., 2008). DSS is believed to
damage the intestinal epithelium, causing
severe inflammation. Neutralization of IL-
22 had a profound impact on the restora-
tion of tissue integrity, suggesting that
IL-22 is important for the wound-healing
response. Another line of evidence for
the tissue-protective role of RORgt+
ILC-derived IL-22 comes from a thymic
regeneration model. Following sublethal
irradiation, IL-22-producing RORgt+ ILCs
were required to protect medullary and
cortical thymic epithelial cells (Dudakov
et al., 2012).
An important and largely unresolved
question is which gene-expression net-
works in epithelial cells are controlled
by IL-22. It has been shown that treat-
ment of colonic explant cultures with IL-
22 leads to the upregulation of a small
family of antimicrobial lectin-like proteins
(Reg3b and Reg3g) and of other antimi-
crobial proteins (e.g., S100A8, S100A9,
SAA3, and lactotransferrin) (Zheng et al.,
2008). However, it remains unknown
whether these genes are causally linked
to the protection of epithelial cells or to
the control of epithelial repair.
It is intriguing that IL-22-producing
RORgt+ ILCs reside in cryptopatches of
the small intestine that directly underlie
the crypts that contain stem cells and
Paneth cells. Although Paneth cells are
widely known to produce and secrete
antimicrobial proteins, they have also
recently been shown to provide niche
support for a population of intestinal
stem cells (also referred to as crypt-basecolumnar cells) that reside at the bottom
of crypts, interspersed among the Paneth
cells (Sato et al., 2011). Paneth cells ex-
press the proteins EGF, TGF-a, Wnt3,
and the Notch ligand Dll4, all of which
are required for stem cell maintenance.
Therefore, it has been hypothesized that
RORgt+ ILCs control epithelial renewal
and adaptation in response to damage by
using IL-22 signaling to control the rate at
which stem cells generate differentiating
daughter cells (Sanos et al., 2011). The
study in this issue of Immunity by Hanash
et al. (2012) now provides evidence that
both Paneth cells and stem cells express
the IL-22 receptor and can, therefore,
receive IL-22 signals. To investigate the
protective effect of IL-22 on Paneth cells
and stem cells, Hanash et al. analyzed
stem cell and Paneth cell maintenance
in a mouse model of graft-versus-host
disease (GvHD). GvHD is a common and
severe clinical complication of alloge-
neic bone marrow transplantation, during
which graft-derived T cells attack alloge-
neic, radio-resistant cells of the host.
The damage to host cells tends to be
most pronounced at mucosal surfaces,
such as those of the gastrointestinal
tract. GvHD is considered to be a funda-
mental obstacle to the clinical success
of bone marrow transplantation. There-
fore, research into signals that may regu-
late the sensitivity of host cells to GvHD
has wide ramifications and therapeutic
implications.
Hanash et al. (2012) show that neu-
tralization of IL-22 leads to enhanced
lethality in an experimental model of
GvHD. Surprisingly, IL-22 deficiency in
donor-derived cells had no or only mini-
mal effects on the survival from GvHD,
whereas IL-22 deficiency in the lethally
irradiated recipient mice led to acceler-
ated mortality and aggravated GvHD
pathology. These data indicated that
a radiation-resistant population of cells,
subsequently identified as RORgt+ ILCs,
is an important source of IL-22. Following
lethal irradiation and bone marrow trans-
plantation in the absence of allo-reactive
T cells, RORgt+ ILCs did not decline for
many days, and even after 3 months, in
contrast to T lymphocytes, the majority
of RORgt+ ILCs remained host derived.
These data demonstrate that RORgt+
ILCs are maintained after lethal irra-
diation. Although IL-22-deficient mice
showed increased mortality from GvHD,Immunity 37there were no differences in inflamma-
tion-related parameters. This raised the
possibility that the aggravated clinical
course was due to increased damage to
epithelial cells. To this end, the authors
used a reporter mouse to directly visualize
stem cells. They show that stem cells
were decreased following GvHD, prob-
ably due to attack by allo-reactive
T cells. Importantly, IL-22-deficient mice
showed an even more dramatic reduction
of stem cells due to an increased rate of
apoptosis when stem cells were deprived
of IL-22 signals. Collectively, the data
demonstrate for the first time that IL-22
produced by RORgt+ ILCs introduces
changes in either stem cells themselves
or in their niche cells that protect them
against damage, such as that occurring
in the context of lethal GvHD (Figure 1).
The above finding represents an im-
portant starting point in addressing sev-
eral crucial and outstanding questions.
It remains to be shown which IL-22-
controlled genes are involved in maintain-
ing epithelial integrity and in protecting
stem cells against damage. The Reg3
family of genes is certainly under the
control of IL-22 (Sanos et al., 2011).
Furthermore, IL-22-deficient mice suffer-
ing from GvHD have reduced epithelial-
barrier function. However, it is not yet
clear whether these antimicrobial lectins
can directly influence stem cell survival.
In addition, although Reg3 proteins are
expressed by Paneth cells, they are
unlikely to be found in stem cells. Thus,
if Reg3 proteins are involved in the pro-
tection of intestinal stem cells, they act
in a stem cell-extrinsic fashion. In future
work, the gene-expression patterns of
stem cells in the presence and absence
of RORgt+ ILCs or IL-22 need to be
analyzed for identification of candidate
genes that directly affect their mainte-
nance and susceptibility to damage. It is
intriguing that Hanash et al. (2012) have
identified IL-22 as having a strong effect
on the gene-expression pattern of Paneth
cells, because these cells have recently
been identified as the intestinal stem cell
niche (Sato et al., 2011). Stem cell niches
provide tunable signals that adjust stem
cell differentiation and renewal to main-
tain organ homeostasis and function.
Niche signals are provided in the form
of adjustable molecular gradients of a
few central signaling pathways, including
Wnt, Bmp, and Fgf. How these gradients, August 24, 2012 ª2012 Elsevier Inc. 197
Figure 1. Protection of the Stem Cell Niche by IL-22
During steady state, RORgt+ ILCs located in intestinal cryptopatches and intestinal lymphoid follicles
produce IL-22, inducing a gene-expression program in Paneth cells and stem cells that protects against
damage (left panel). In particular, ILC-produced IL-22 is required for expression of the antimicrobial lectin
Reg3g by Paneth cells. Under GvHD conditions, allo-reactive T cells recognize Paneth cells and/or intes-
tinal stem cells, leading to the loss of both. However, tissue-protective IL-22 limits the damage. In IL-22-
deficient mice (right panel), epithelial cells are deprived of tissue-protective factors, and allo-reactive
T cells can cause significantly more damage, leading to a more severe clinical picture of GvHD.
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signals, specifically those from hema-
topoietic cells, is currently unknown. It
will be an important line of future research
to probe whether niche signals are modi-
fied by signals from ILC. Such future198 Immunity 37, August 24, 2012 ª2012 Elsstudies have the potential to unravel new
molecular pathways by which immune
cells regulate stem cell differentiation
and renewal, thereby securing organ
homeostasis and function. This has obvi-
ous therapeutic ramifications for GvHDevier Inc.and also for inflammatory bowel diseases
and mucosal infections.REFERENCES
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